CTRI/2025/12/098293尚未招募不适用
Evaluation of the Irritation Potential of Skincare Formulation (Anaboom Stem Serum) on Sensitive Skin in Healthy Human Subjects through Patch Test Method.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 26
- 试验地点
- 1
研究概览
简要总结
This study aims to evaluate the irritation potential of Anaboom Stem Serum on healthy individuals with sensitive skin. A total of 26 subjects (13 male and 13 female), aged between 18 and 65 years, will be enrolled to assess the product’s safety and tolerability through a single-application closed patch test. Dermatological assessment will be conducted using the Primary Irritation Patch Test method as per BIS Standard IS 4011:2018.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Female and male Asian Indian subjects with phototype III-V.
- •Healthy human subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up) 3)Between 18 and 65 years of age.
- •Skin is healthy on the studied anatomic unit (e.g., free of eczema, wounds, inflammatory scar) 5)Subjects representing sensitive skin type (as per the Baumann’s questionnaire answered by subjects).
排除标准
- •For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2)Having eczema, psoriasis, lichen planus, vitiligo at the test site of analysis.
- •Having disorder of the healing at the test site of analysis 4)Having rhinitis, allergic conjunctivitis or rhino sinusitis 5)Having hypersensitivity/ allergy to any cosmetics, perfumes and/or conservatives in cosmetic products, etc.
- •Having an allergy to plaster 7)Having a food allergy 8)Having scar excessive terminal hair or tattoo on studied area 9)Having a cardiovascular pathology (taking a beta blocker treatment) 10)Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
- •Taking a retinoid-based treatment by general or oral route 12)Taking specific treatment on the back.
- •Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study 14)Having miliaria (prickly heat) on the back.
- •Presenting too many naevus on the back 16)Having high pilosity on the back.
- •Refusing to follow the restrictions below during the study:During the first 24 hours (after patch application), neither cosmetic products nor water must be applied on the back, Till the follow up period of until T8 days, only use of water is acceptable from the first reading i.e., T2 days (24 hours after the patch removal), Do not practice an intensive sport activity during the first 24 hours (until the removal of the patches), Do not expose the back to the sun.
研究者
Dr Niharika Salian
MASCOT-SPINCONTROL India Pvt. Ltd.
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Safety assessment of cosmetic productsCTRI/2023/12/060894Mosaic wellness pvt ltd26
尚未招募
不适用
A Study to assess safety of Products on human volunteersCTRI/2025/03/081748Aurella Belle26
尚未招募
不适用
Safety assessment of cosmetic product on human subjectsCTRI/2025/02/081386First Impression24
已完成
不适用
Safety check of cosmetic products on SkinCTRI/2025/01/078899OJB Herbals Pvt Ltd26
已完成
不适用
A Study to check Safety of Products on Healthy AdultsCTRI/2025/01/079056First Impression26